GM2AP1: A Potential Drug Target for Neurological Disorders (G2761)

Target Name: GM2AP1

NCBI ID: G2761

GM2AP1

Other Name(s): GM2A pseudogene 1 | GM2A activator protein-related processed pseudogene | GM2AP

GM2AP1: A Potential Drug Target for Neurological Disorders

GM2AP1, also known as GM2A pseudogene 1, is a gene that has been identified as a potential drug target or biomarker for various neurological and psychiatric disorders. The gene, which is located on chromosome 6q24, is a candidate gene for several neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

GM2AP1 is a gene that encodes a protein known as GLT-1, which is a key regulator of the blood-brain barrier. The GLT-1 protein is involved in the transport of nutrients and drugs into the brain, and is also involved in the production of neurotransmitters, such as dopamine and serotonin.

Studies have shown that individuals with certain genetic variations in the GM2AP1 gene are at increased risk for developing neurological disorders. For example, individuals with the 蔚4-5 allele, which is a common variation in the GM2AP1 gene, are reported to have an increased risk of developing Alzheimer's disease.

In addition to its role in the blood-brain barrier, GM2AP1 is also involved in several other processes that are relevant to neurological function. For example, the GLT-1 protein is involved in the regulation of ion channels in neuronal action potentials, which is important for the proper functioning of the nervous system.

Furthermore, GM2AP1 is also involved in the regulation of neurotransmitter release from neurons. This is important for the proper functioning of the nervous system, as neurotransmitters are involved in transmitting signals between neurons and are involved in the regulation of various physiological processes, including mood, appetite, and sleep.

In conclusion, GM2AP1 is a gene that has been identified as a potential drug target or biomarker for several neurological and psychiatric disorders. The GLT-1 protein, which is encoded by the GM2AP1 gene, is involved in several important processes that are relevant to neurological function, including the regulation of the blood-brain barrier and the regulation of neurotransmitter release from neurons. Further research is needed to determine the role of GM2AP1 in the development and treatment of neurological and psychiatric disorders.

Protein Name: GM2A Pseudogene 1

The "GM2AP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GM2AP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets